Nautilus Biotechnolgy (NAUT) Live Share Price, Invest From India

Nautilus Biotechnolgy Stock Performance

as on October 23, 2026 at 6:59 am IST

Day's Low
Day's High
$2.54
Day's Price Range
$2.86
$2.61
2.68%
Downside
9.58%
Upside
52 Week's Low
52 Week's High
$0.84
52-Week Price Range
$4.31
$2.61
67.77%
Downside
65.14%
Upside

Nautilus Biotechnolgy share price movements today

Previous Close: $2.71
Open: $2.72
Volume: 7.1M
Market Cap: $324.5M
Day's Low - High: $2.54 - $2.86
52 Week Low - High: $0.84 - $4.31

Nautilus Biotechnolgy Historical Returns

1 Month Return: + 171.16 %
3 Month Return: + 59.41 %
1 Year Return: + 115.08 %
3 Year Return: + 15.32 %
5 Year Return: -47.28 %

Nautilus Biotechnolgy Stock Fundamentals & Key Indicators

Check Nautilus Biotechnolgy market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$324.5M

EPS (TTM)

-0.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.67

Industry PE ratio

-7.49

PEG Ratio

-0.38

EBITDA

-53.7M

Revenue (TTM)

190.0K

Profit Margin

-919.47%

Return On Equity TTM

-37.58%

Nautilus Biotechnolgy vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nautilus Biotechnolgy with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Nautilus Biotechnolgy	Buy	$324.5M	-47.28%	-5.67	-919.47%	0.00%
Moderna	Neutral	$96.6B	-24.72%	-30.34	-12.57%	0.00%
BeOne Medicines	StrongBuy	$43.7B	NA	26.25	87.82%	0.00%
Vertex Pharmaceuticals	StrongBuy	$130.4B	185.81%	29.71	86.04%	0.00%
Regeneron	Buy	$83.1B	40.76%	19.28	84.86%	0.46%

Stock Returns calculator for Nautilus Biotechnolgy Stock including INR - Dollar returns

The Nautilus Biotechnolgy stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Nautilus Biotechnolgy investment value today

Current value as on today

₹2,23,852

Returns

₹1,23,852

(+123.85%)

Returns from Nautilus Biotechnolgy Stock

₹1,07,143 (+107.14%)

Dollar Impact

₹16,709 (+16.71%)

Analyst Recommendation on Nautilus Biotechnolgy Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Nautilus Biotechnolgy. Average target price of $3.83

Nautilus Biotechnolgy Share Price Target

Get share price movements and forecasts by analysts on Nautilus Biotechnolgy.

What analysts predicted

31.85%UPSIDE

Target Price

$3.83

Current Price

$2.61

Analyzed by

2 Analysts

High

Target

$3.83

Low

$3.5

Nautilus Biotechnolgy target price $3.83, a slight upside of 31.85% compared to current price of $2.61. According to 2 analysts rating.

Indian Investors' Interest in Nautilus Biotechnolgy Stock

Investment in Nautilus Biotechnolgy Shares on INDmoney has grown by 761.29% in the last 30 days, indicating increased investment activity.

Time period: September 23, 2026 to October 23, 2026

Change:761.29% versus previous 30 day period

Search interest for Nautilus Biotechnolgy Stock has increased by 1681% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 23, 2026 to October 23, 2026

Change:1681% versus previous 30 day period

Nautilus Biotechnolgy Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	0
Gross Profit	-1	-1	-1	-6	-	-	-	-1	-1	1
Operating Income	-21	-20	-19	-19	-18	-17	-15	-15	-16	-15
EBITDA	-17	-16	-14	-16	-17	-15	-13	-12	-13	-14
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-18	-18	-16	-17	-16	-15	-13	-13	-14	-14
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-18	-18	-16	-17	-16	-15	-13	-13	-14	-14
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	693.16%

Nautilus Biotechnolgy Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-2	-2	-	-5	-6	-6
Operating Income	-111	-10	-15	-50	-63	-76	-81	-66
EBITDA	626	-9	-13	-47	-60	-57	-64	-52
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	738	0	2	2	3	5	6	6
Income Before Tax	626	-9	-15	-50	-57	-63	-70	-59
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	626	-9	-15	-50	-57	-63	-70	-59
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Nautilus Biotechnolgy Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-18	-18	-16	-17	-16	-15	-13	-13	-14	-14
Operating Cash Flow	-16	-15	-13	-14	-13	-13	-11	-12	-13	-13
Investing Cash Flow	22	14	-7	37	19	14	0	0	14	12
Financing Cash Flow	0	0	0	0	0	0	-	0	1	0
Change in Cash	6	0	-20	23	5	1	-10	-11	2	-1

Nautilus Biotechnolgy Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	626	-9	-15	-50	-57	-63	-70	-59
Operating Cash Flow	-238	-9	-13	-39	-45	-51	-59	-50
Investing Cash Flow	1	4	-25	-138	-25	-43	66	35
Financing Cash Flow	145,186	0	75	327	0	0	1	0
Change in Cash	1	0	36	149	-70	-95	8	-15

Global Institutional Holdings in Nautilus Biotechnolgy

Check out the Institutions with significant holdings in Nautilus Biotechnolgy.

Funds	Holdings
Joseph Edelman	9.14%
Vanguard	2.26%
VANGUARD INDEX FUNDS	1.93%
iShares	1.66%
Fidelity Concord Street Trust	0.37%

See all

Insights on Nautilus Biotechnolgy

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, NAUT stock has moved up by 25.5%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 205.7% return, outperforming this stock by 190.4%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 815.5% return, outperforming this stock by 700.4%

About Nautilus Biotechnolgy

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Organisation	Nautilus Biotechnolgy
Headquarters	2701 Eastlake Avenue East, Seattle, WA, 98102, US
Industry	Biotechnology
CEO	Sujal Patel

Key Management of Nautilus Biotechnolgy

Name	Title
Ms. Anna Mowry	CFO & Treasurer
Mr. Matthew B. Murphy ESQ.	General Counsel
Ms. Amber Faust	Vice President of Global Sales
Ms. Jamie Rose Kuhar Ph.D.	Vice President of Marketing
Ms. Gwen E. Weld	Chief People Officer
Dr. Subra Sankar Ph.D.	Senior Vice President of Product Development
Mr. Sujal M. Patel	Co-Founder, CEO, President, Secretary & Director
Dr. Parag Mallick Ph.D.	Co-Founder, Chief Scientist & Director

FAQs

What is Nautilus Biotechnolgy share price today?

Nautilus Biotechnolgy share price today is $2.61 as on October 23, 2026 at 1:29 am IST at the close of the market. Nautilus Biotechnolgy share today touched a day high of $2.86 and a low of $2.54.

What is the 52 week high and 52 week low for Nautilus Biotechnolgy share?

Nautilus Biotechnolgy share touched a 52 week high of $4.31 on March 25, 2026 and a 52 week low of $0.84 on August 7, 2026. Nautilus Biotechnolgy stock price today i.e. October 23, 2026 at 1:29 am IST is closed at $2.61,which is 39.44% down from its 52 week high and 210.31% up from its 52 week low.

What is Nautilus Biotechnolgy's market capitalisation today?

Nautilus Biotechnolgy market capitalisation is $0.00T as on October 23, 2026 at 1:29 am IST.

How to invest in Nautilus Biotechnolgy Stock (NAUT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nautilus Biotechnolgy on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Nautilus Biotechnolgy Stock (NAUT) from India?

Indian investors can start investing in Nautilus Biotechnolgy (NAUT) shares with as little as ₹94.81749725341797 or $1 (as of October 23, 2026 at 4:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹948.17 in Nautilus Biotechnolgy stock (as per the Rupee-Dollar exchange rate as on October 23, 2026 at 4:41 am IST). Based on Nautilus Biotechnolgy share’s latest price of $2.61 as on October 23, 2026 at 1:29 am IST, you will get 3.8314 shares of Nautilus Biotechnolgy. Learn more about fractional shares .

What are the returns that Nautilus Biotechnolgy has given to Indian investors in the last 5 years?

Nautilus Biotechnolgy stock has given -47.28% share price returns and 26.58% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?